Stockreport

Regen BioPharma, Inc. to Discuss Plans to Move Forward with HemaXellerate into Clinical Phase 1 at the Emerging Growth Conference on April 4, 2024 [Yahoo! Finance]

Regen Biopharma, Inc. Common  (RGBP) 
NASDAQ:AMEX Investor Relations: regenbiopharmainc.com/investor-relations.html
PDF SAN DIEGO April 2, 2024 /PRNewswire/ -- Regen BioPharma, Inc. (OTC PINK: RGBP) (OTC PINK: RGBPP), a biotechnology company advancing a diverse pre-clinical pipeline span [Read more]